Phase I clinical trial of a HER-2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patients (Q40358903)
Jump to navigation
Jump to search
scientific article published on October 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I clinical trial of a HER-2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patients |
scientific article published on October 2005 |
Statements
1 reference
Phase I clinical trial of a HER-2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patients (English)
1 reference
Matthew T Hueman
1 reference
Zia A Dehqanzada
1 reference
Thomas E Novak
1 reference
Jennifer M Gurney
1 reference
Michael M Woll
1 reference
Gayle B Ryan
1 reference
Catherine E Storrer
1 reference
Christine Fisher
1 reference
David G McLeod
1 reference
Constantine G Ioannides
1 reference
Sathibalan Ponniah
1 reference
George E Peoples
1 reference
1 October 2005
1 reference
1 reference
Identifiers
1 reference